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Abstract
Hexabromocyclododecane (HBCD) is a brominated flame retardant (BFR) that accumulates in humans and affects the nerv-
ous system. To elucidate the mechanisms of HBCD neurotoxicity, we used transcriptomic profiling in brains of female mice 
exposed through their diet to HBCD (199 mg/kg body weight per day) for 28 days and compared with those of neuronal N2A 
and NSC-19 cell lines exposed to 1 or 2 µM HBCD. Similar pathways and functions were affected both in vivo and in vitro, 
including  Ca2+ and  Zn2+ signalling, glutamatergic neuron activity, apoptosis, and oxidative stress. Release of cytosolic free 
 Zn2+ by HBCD was confirmed in N2A cells. This  Zn2+ release was partially quenched by the antioxidant N-acetyl cysteine 
indicating that, in accordance with transcriptomic analysis, free radical formation is involved in HBCD toxicity. To inves-
tigate the effects of HBCD in excitable cells, we isolated mouse hippocampal neurons and monitored  Ca2+ signalling trig-
gered by extracellular glutamate or zinc, which are co-released pre-synaptically to trigger postsynaptic signalling. In control 
cells application of zinc or glutamate triggered a rapid rise of intracellular  [Ca2+]. Treatment of the cultures with 1 µM of 
HBCD was sufficient to reduce the glutamate-dependent  Ca2+ signal by 50%. The effect of HBCD on zinc-dependent  Ca2+ 
signalling was even more pronounced, resulting in the reduction of the  Ca2+ signal with 86% inhibition at 1 µM HBCD. Our 
results show that low concentrations of HBCD affect neural signalling in mouse brain acting through dysregulation of  Ca2+ 
and  Zn2+ homeostasis.
Keywords BFR · Neurotoxicity · Transcriptomics · Glutamate · Oestrogen · Androgen · Dihydrotestosterone · Prolactin · 
GnRH
Introduction
1,2,5,6,9,10-Hexabromocyclododecane (HBCD) is a bro-
minated flame retardant (BFR), mainly used in thermal 
insulation foams in building and construction, as well as in 
plastics and textiles. High quantities were used due to bans 
on many other BFRs, especially in Europe (Birnbaum and 
Staskal 2004; Chain EPoCitF 2012; Law et al. 2005). In 
2013 HBCD was listed in Annex A (POP for elimination) 
under the Stockholm convention on persistent organic pol-
lutants (POPs), with specific exceptions. Namely, HBCD 
can be still produced and used for expanded polystyrene and 
extruded polystyrene in buildings.
HBCD has been detected in the environment worldwide. 
It has been found in samples of urban and rural air (Covaci 
et al. 2006; Vorkamp et al. 2012), soil (Drage et al. 2016; 
Wu et al. 2016a), water (de Wit et al. 2010), and household 
dust (de Wit et al. 2012; Schreder and La Guardia 2014). 
HBCD is a lipophilic compound (log Kow = 5.81) (Ameri-
can Chemistry Council 2001) that bioaccumulates through 
food webs, and concentrations are particularly high in oily 
fish, such as salmon (Chain EPoCitF 2012; Fromme et al. 
2016). The main sources of human exposure to HBCD are 
contaminated food, breast milk, and inhalation from pol-
luted indoor dust and air (Chain EPoCitF 2012; Fromme 
et al. 2016). Presence of HBCD in human breast milk has 
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been identified in samples from various countries including 
Canada, United States, Europe and China. HBCD concentra-
tions in breast milk increased from 1980 to 2002, but have 
reached a stable level since (Eljarrat et al. 2009; Fängström 
et al. 2008; Ryan and Rawn 2014; Shi et al. 2013). HBCD 
has been also measured in human serum (Rawn et al. 2014b; 
Roosens et al. 2009) and human foetal liver and placental 
tissues (Rawn et al. 2014a).
HBCD has the potential to cause histological changes in 
liver, thymus and thyroid (Maranghi et al. 2013; van der Ven 
et al. 2006). It can induce adverse effects to the reproduc-
tive, endocrine, and central nervous systems (Chain EPoC-
itF 2012; Maranghi et al. 2013; Rasinger et al. 2014; van 
der Ven et al. 2006, 2009). Notably, 28-day oral exposure 
to HBCD increased thyroid weight and activity of the thy-
roxine (T4) metabolising enzyme T4-UGT, and decreased 
total circulating thyroxin in female Wistar rats (van der Ven 
et al. 2006). These effects are accompanied by evidence of 
suppressed thyroid hormone receptor-mediated transcription 
(Ibhazehiebo et al. 2011). Along with effects on the thyroid 
hormone system, the most sensitive end-points in animal 
studies have related to neurodevelopment (Chain EPoCitF 
2012).
Due to its lipophilicity, HBCD can pass the blood brain 
barrier (BBB) and accumulate in the brain (Covaci et al. 
2006; Rasinger et al. 2014). Its ability to cause neurotoxicity 
has been evidenced by developmental behavioural effects 
seen after exposure (Eriksson et al. 2006; Lilienthal et al. 
2009). In mice exposed to HBCD, effects on memory and 
learning have been reported at single oral doses between 
0.9 and 13.5 mg/kg body weight (Eriksson et al. 2006), and 
in rats exposed to HBCD, effects on dopamine-dependent 
behaviour and hearing function were observed (Lilienthal 
et al. 2009). These effects may be related to a reduction in 
expression of the striatal dopamine transporter and vesic-
ular monoamine transporter 2, as observed in studies in 
C57BL/6J mice (Genskow et al. 2015). However, HBCD 
has also been shown to inhibit dopamine uptake with a half 
maximal inhibitory concentration  (IC50) of 4 µM (Marius-
sen and Fonnum 2003). In the same study HBCD was also 
seen to inhibit glutamate uptake at concentrations as low 
as 1 µM, but it never achieved more than 50% inhibition 
(Mariussen and Fonnum 2003). In addition, accumulation 
of xenobiotics in the brain has been seen to cause a chronic 
inflammatory response which has been found to be linked 
with neurodegenerative conditions such as Alzheimer’s and 
Parkinson diseases (DeLegge and Smoke 2008). In vivo 
studies in mice have shown that while exposure to BFRs 
during gestation may lead to congenital effects (Curran et al. 
2011), later exposure during brain development can cause 
disturbed spontaneous behaviour in adults (Alm et al. 2008; 
Eriksson et al. 2006; Viberg et al. 2003).
In spite of the valuable information on the effects of 
HBCD on dopaminergic and glutamatergic neuronal func-
tion, knowledge of intracellular signalling pathways modu-
lated by HBCD in neurons is limited. One such mechanism is 
likely interference with cellular  Ca2+ homeostasis that is cru-
cial for learning and memory function. HBCD (2–200 nM) 
was reported to reduce cytosolic free  Ca2+ concentrations 
and increase  Ca2+ content of the sarcoplasmic reticulum in 
rat H9C2 cardiomyocyte cell line (Wu et al. 2016b). In PC12 
cells, 2 µM HBCD inhibited depolarisation-evoked  [Ca2+]i 
transients and associated catecholamine release (Dingemans 
et al. 2009). HBCD also inhibited the sarcoplasmic-endo-
plasmic reticulum  Ca2+-ATPase (SERCA) in neuroblastoma 
SH-SY5Y cells through interference with its ATP binding at 
an  IC50 of 2.7 µM (Al-Mousa and Michelangeli 2014). As 
both pre- and post-synaptic events are dependent on  Ca2+ 
signalling, this mechanism of action could have widespread 
consequences for neuronal function.
We sought to take an unbiased approach to explore molec-
ular events leading to neurotoxicity of HBCD in mouse, inte-
grating in vivo and in vitro experiments. This allowed us to 
explore mechanisms of action indicated in the animal experi-
ment and to differentiate between direct effects of HBCD on 
the brain from potential indirect endocrine effects, caused by 
disruption of sex steroids (Rasinger et al. 2014) and thyroid 
hormones (van der Ven et al. 2006). We used transcriptomics 
to interrogate HBCD responses on gene expression in mouse 
brain in vivo as well as in two neuronally derived mouse 
cell lines, N2A and NSC19. Post-transcriptomics hypothesis 
driven experimentation on cell lines and isolated primary 
hippocampal cells demonstrated pronounced HBCD disrup-
tion of  Ca2+ and  Zn2+ homeostasis.
Materials and methods
Animal experiment, tissue sampling and HBCD 
analysis
Juvenile female BALB/c mice (n = 12, average weight 
13–15 g) were purchased from Charles River (UK). A total 
of six mice (3 mice per cage) were exposed to a nominal 
dose of 199 mg/kg body weight per day HBCD through the 
diet; another six mice were fed an un-spiked control diet. 
The animal experiment was carried out under a project 
licence in accordance with the UK Home Office Animals 
(Scientific Procedures) Act, 1986 and was performed as 
previously described by us (Maranghi et al. 2013; Rasinger 
et al. 2014). The experimental diet used was in accordance 
with the standard rodent diet formulation AIN-93 G with the 
exception that freeze-dried Atlantic salmon (Salmo salar) 
was used as the main protein and fat source. The salmon 
used in the present work was raised specifically for the 
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study on plant and vegetable oil substituted fish feed, which 
yielded exceptionally low background levels of contami-
nants in the fish (Berntssen et al. 2010). A technical mixture 
of HBCD (1.3 g/kg feed, purity: 99.2%; Applied Biosys-
tems, UK) was dissolved and diluted in 100% dimethylsul-
foxide (DMSO) and mixed into the feed at a concentration 
of 1.3 mg/kg feed. The control diet was adjusted to the same 
final DMSO content (0.4 mL/kg feed) as the HBCD spiked 
feed. This dietary concentration resulted in a daily dose of 
199 mg/kg body weight and was in an identical experiment 
found to give an accumulation of HBCD within the brain tis-
sue of 4.7 µg/g dry weight (Rasinger et al. 2014), which on a 
wet weight basis corresponds to approximately 7.3 µmol/kg. 
This dose did not affect feed consumption or weight gain and 
there were no overt changes in behaviour (data not shown). 
After 28 days of exposure, brains were sampled and prepared 
for analysis as described before (Rasinger et al. 2014). In 
short, the whole brain was excised from the cranial cavity 
and dissected on ice. Left cortices were flash-frozen in liq-
uid nitrogen and ground in a liquid nitrogen cooled mortar 
and pestle. Frozen powdered tissue was then partitioned in 
aliquots and stored at − 80 °C.
RNA extraction and transcriptomic analysis 
of murine juvenile brains
Total RNA was extracted from powdered brain tissue 
of HBCD exposed and control mice (n = 6 per group) as 
described by us before (Rasinger et al. 2014). In short, total 
RNA was extracted using Trizol (Invitrogen, Life Technolo-
gies, USA) and the Qiagen RNeasy-Mini kit (Qiagen, Can-
ada). RNA purity was assessed using a Nanodrop ND-100 
UV–Vis Spectrophotometer (Nanodrop Technologies, USA) 
and RNA quality and integrity were assessed using the Agi-
lent 2100 Bioanalyzer in combination with the RNA 6000 
LabChip kit (Agilent Technologies, USA). Gene expression 
microarray analysis was performed using GeneChip Mouse 
Exon 1.0 ST arrays (Affymetrix, USA) following the manu-
facturer’s instructions. Array images were acquired using 
a GeneChip Scanner 3000 (Affymetrix, USA). Array data 
were normalised using RMAsketch as implemented in the 
Affymetrix Expression Console.
Primary mouse hippocampal culture
Primary hippocampal cultures were obtained from postnatal 
P0-P2 days old mice that were anesthetised with isoflurane 
according to approved protocols. Hippocampi were removed 
and immediately placed in Hank’s balanced salt solution 
with HEPES (20 mM) and triturated in plating medium 
consisting of Neurobasal-A medium supplemented with 
5% defined FBS, 2% B27, 2 mM Glutamax I, and 1 μg/mL 
gentamicin. Cells were then seeded on Poly-d lysine coated 
glass coverslips, in plating medium. 48 h following plating 
medium was replaced by serum-free culture medium that 
consisted of Neurobasal-A, 2 mM Glutamax I, and 2% B27.
Cell line culture
N2A and NSC19 cells were kindly provided by Prof. Joerg 
Bartsch (Philipps-Universität, Marburg, Germany). Both 
the cell lines were cultured in DMEM with 110 mg/sodium 
pyruvate, supplemented with 100 units/mL penicillin, 100 
units/mL streptomycin, and 10% fetal bovine serum (FBS). 
Cells were cultured at 37 °C in a humidified atmosphere 
with 5%  CO2.
MTT assay
To test the cytotoxicity of HBCD, cells were seeded into 
96-well plates in 100 µL of DMEM. After 24 h of cell 
attachment, the cells were exposed to a series of HBCD con-
centrations. Serial stock solutions of HBCD were prepared 
in DMSO; the final concentration of DMSO in HBCD-con-
taining medium was below 0.1%, which is well tolerated by 
neuroblastoma cells (Xia et al. 2008). Control wells received 
0.1% DMSO only. To perform a (3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium bromide (MTT, SIGMA, UK) 
colorimetric assay, cells seeded into 96-well plates (density: 
1 × 104 cells/well) were exposed to HBCD at concentra-
tions between 1.56 and 50 µM for 48 h. Following HBCD 
exposure, the medium was removed and 100 µL of the MTT 
salt diluted in fresh media at a concentration of 0.5 mg/mL 
were added to each well. Cells were incubated for 4 h in 
incubator at 37 °C and 5%  CO2. After incubation, the MTT 
salt was replaced by 20 µL of DMSO to dissolve the purple 
formazan. The absorbance was measured spectrophotometri-
cally at a wavelength of 570 nm. The background absorb-
ance was measured at 650 nm and was subtracted from the 
first measurement.
Caspase‑3 assay
Caspase-3 activity was measured as a marker of apoptosis 
using a commercial kit (Caspase-3 assay, Invitrogen, UK). 
Cells seeded into a 12-well plate (density of 1 × 106 cells/
well) were exposed to HBCD at four different concentra-
tions: 1, 2, 4 or 8 µM for 24 h. After HBCD treatments, 
cells were collected, washed twice with Phosphate-Buffered 
Saline (PBS, GIBCO, UK) and the Caspase-3 assay was 
performed as per recommendations of the supplier.
Analysis of intracellular  Zn2+
Free and loosely bound  Zn2+ was detected in the neuro-
blastoma N2A cell line using the zinc-specific fluorescent 
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dye Zynpyr-1 (Mellitech, France; Kd = 0.7 ± 0.1 nM). Zinc 
assays were performed in cells grown in a 96-well plate, 
detecting the fluorescence with a fluorescence plate reader. 
Cells were exposed to HBCD at different concentrations for 
24 h.
After treatments on coverslips or in a 96-well plate, cells 
were washed and kept moisturised with Ringer buffer (3 M 
NaCl, 2.7 M KCl, 0.8 M  MgCl2, 2 M Hepes, 0.75 M glu-
cose, 1.8 M  CaCl2, calibrated to pH 7.4). Zinpyr-1 dye was 
diluted in PBS at a concentration of 16 µM. After exposure 
to the dye for 30 s, cells were washed with PBS for 30 s. The 
fluorescence was measured with the plate reader Thermo 
Scientific Fluoroskan Ascent at an excitation wavelength of 
480 nm and emission wavelength of 530 nm. Fluorescence 
emission was normalized to the DMSO control in each row 
separately and the  Zn2+-induced fluorescence expressed as 
fold-change relative to the control.
Specificity of the zinc signal was verified by pre-treat-
ment (2 h) with the zinc chelator diethyldithiocarbamate 
(DEDTC, Sigma Aldrich) at 50 µM. Alternatively, cells 
were pre-treated with 10 µM of the zinc chelator and anti-
oxidant N-acetylcysteine (NAC) for 1 h. Activation of the 
NO pathway was investigated performing a 1 h treatment 
with 10 µM of the NO synthase blocker L-NAME before 
HBCD exposure.
Ca2+ imaging
The intracellular concentration of free  Ca2+ was imaged in 
cultured primary hippocampal neural cells. Cultures were 
maintained for 9–12 days before imaging and then treated 
with HBCD at the indicated concentrations for 24 h. For 
intracellular  Ca2+ measurements, cultures were loaded 
with Fura-2 AM (5 µM, 20 min) and fluorescent imaging 
was performed as described previously, using the ratio of 
the emission signal following excitation with 340 nm and 
380 nm (Besser et al. 2009). Representative traces of flu-
orescent signal changes are presented. The initial rate of 
the response following addition of glutamate or  Zn2+ was 
determined using a linear fit, and the averaged response of 
at least seven slides from three different cultures is presented 
in the bar graphs. Since the AM dye requires hydrolysis by 
intracellular esterases to remain within the cell, only live 
neurons accumulate Fura-2 and are used for the subsequent 
 Ca2+—response analysis. To determine the survival of 
cells following HBCD treatments, representative cultures 
were washed following the 24 h treatment and mounting 
medium containing DAPI (Santa Cruz Biotechnology) 
was applied. Coverslips were observed using fluorescence 
microscope Axioscop 2 (Zeiss) with the appropriate filters 
at 10 × magnification.
RNA extraction and transcriptomic analysis of N2A 
and NSC19 cells
N2A and NSC19 cells were exposed to either 1 or 2 µM 
of HBCD, a DMSO control or a negative control (medium 
only). After 24 h exposure, total RNA was extracted and 
subjected to a custom two-colour microarray analysis 
(mouse OpArray, 4.0, Operon, USA) as detailed by us before 
(Rasinger et al. 2014). In brief, total RNA was extracted 
using Trizol (Invitrogen, Life Technologies, USA) and the 
Qiagen RNeasy-Mini kit (Qiagen, Canada). RNA purity was 
assessed using a Nanodrop ND-100 UV–Vis Spectropho-
tometer (Nanodrop Technologies, USA) and RNA quality 
and integrity were assessed using the Agilent 2100 Bio-
analyzer in combination with the RNA 6000 LabChip kit 
(Agilent Technologies, USA). A cDNA pool generated from 
a pool of RNA of all samples was used as reference in two-
colour microarray assays. Superscript III™ Indirect labelling 
system (Invitrogen) and Cy3 or Cy5 fluorescent dyes (Mono-
Reactive Dye Pack, Amersham Biosciences) were used to 
create, purify and fluorescence-label aminoallyl complemen-
tary DNA (cDNA) following the manufacturer’s (Invitro-
gen) instructions for indirect labelling. Cy3 (reference) and 
Cy5 (sample) labelled cDNA were hybridised to microar-
rays spotted in house with 35,852 65-mer oligonucleotide 
probes (mouse OpArray, 4.0, Operon, USA), according to 
the manufacturer’s instructions. Images of hybridised slides 
were acquired using  ScanArray® Express (Perkin Elmer Inc., 
USA). Acquired images were interpreted using the Blue-
Fuse (BlueGnome) software. The arrays were first evaluated 
to exclude spots, which were miss-aligned or in areas with 
high background. Spot intensities were then calculated with 
Bayesian background correction filtering out those with low 
confidence (p < 0.05). Prior to normalisation all genes scor-
ing less than 0.1 in their probability of biological signal in 
more than 25% of arrays were removed using the Genefilter 
Bioconductor version 2.4 package. This filter left around 
50% of total genes on the array. Loess and median scale 
normalisation were applied to normalise data within and 
between arrays, respectively.
Transcriptomics statistics and bioinformatics
Statistical analyses of the filtered and normalized in vivo 
and in vitro microarray data were performed as described in 
Rasinger et al. (2014). In short, using the packages LIMMA 
and Multtest of the Bioconductor software suite (version 
2.4, http://www.bioconductor.org) differential expression 
was identified and multiple test correction was applied to 
all p values. Genes for treatment effects were regarded as 
differentially expressed if the p value was below 0.05 and 
the multiple test corrected p value, the false discovery rate 
(FDR) was below 20%. Genes passing these thresholds were 
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imported into the Ingenuity Pathway Analysis software suite 
and mapped onto their corresponding objects in the Inge-
nuity Knowledge Base (IPA, Ingenuity Systems, USA). To 
compare and contrast individual and common responses to 
HBCD exposure in gene expression, successfully mapped 
genes were subjected to an IPA Core Analysis (default set-
tings) followed by an IPA Comparison Analysis (default set-
tings). The global Ingenuity Knowledge Base (Genes Only) 
was used as a reference set and included endogenous chemi-
cals; both direct and indirect relationships were included in 
networks that contained at least one gene from the imported 
list (‘‘Focus Genes’’). Only relationships based on Experi-
mental Observations were considered. The p values reported 
for over-representation of genes in functional or pathway 
processes are from a right-tailed Fisher’s exact test and a p 
value cut-off of 0.05 was applied.
Real‑time quantitative PCR (qPCR)
To validate the microarray assays, synthesis of cDNA was 
performed using 5 µg of total- RNA previously used for 
microarrays. cDNA was generated using Superscript III as 
described by the manufacturer (Invitrogen). Primer pairs 
were synthesised by PrimerDesign or Qiagen (QuantiTect 
Primer Assay), and the sequences of primers or the Qiagen 
ID are shown in Supplementary Tables 1A and 1B, respec-
tively. The assays were performed using the ABI PRISM 
7700 therocycler (ABI, USA), carrying out the method as 
described in the SYBR Green SuperMix-UDG Kit (Invit-
rogen). Primer efficiency was tested and a range between 
90 and 110% was considered acceptable. The housekeeping 
gene for qPCR normalisation was selected using GeNorm 
reference gene selection kit (Primerdesign), and gene Gapdh 
was found the least variable housekeeping gene. Quantity 
calculations were performed using the REST (relative 
expression software tool) software (Pfaffl et al. 2002). Sta-
tistical calculation of probability of differential expression 
were based on a randomisation of samples using the Pair 
Wise Fixed Reallocation Randomisation Test (Pfaffl et al. 
2002). REST was set for a number of 1000 randomisations 
during this analysis.
Results
Cell viability and assessment of apoptosis
Cells exposed to HBCD at concentrations between 1.56 and 
50 µM dose-dependent cytotoxicity compared to the control 
(Fig. 1a, b). Cell viability, as measured by the MTT assay, 
was reduced by about 20-30% at concentrations between 1.5 
and 3.15 µM for N2A and NSC-19 cell lines, respectively. At 
concentrations greater than 6.25 µM, cell viability decreased 
by more than 50% for both cell lines and up to 100% at con-
centration of 12.5 µM for N2A cells and 25 µM for NSC-19 
cell line. The EC50 was estimated to be about 5 and 6 µM for 
the N2A and the NSC19 cell lines, respectively (Fig. 1a, b).
Caspase-3 activity was measured as a marker of apoptosis 
in cells exposed for 24 h to HBCD at concentrations ranging 
from 1 to 8 µM. There was a significant (p < 0.05) increase 
in caspase-3 enzymatic activity at 1 and 2 µM HBCD for the 
N2A cell line (Fig. 1c) and at 1 µM for the NSC-19 cell line 
(Fig. 1d). At concentrations higher than these, the caspase-3 
activity showed no difference compared to the control, pre-
sumably because of the loss of viable and functional cells.
Microarray experiments
Fold-change data, associated p- and FDR-values for all sta-
tistically analysed and mapped genes are presented in the 
supplementary material (Supplementary Table 2). In all 
conditions, except one (N2A, 1 µM), there were a greater 
number of genes that were downregulated than upregu-
lated (Table 1). In mice exposed to HBCD through the diet 
(199 mg/kg bw/day) a total of 83 genes were differentially 
regulated, of which 10 were upregulated and 73 downregu-
lated. The greatest number of regulated genes were observed 
in N2A cells treated with 2 µM HBCD. HBCD elicited dis-
tinct and overlapping responses in gene expression in vivo 
and in vitro (Fig. 2, Table 2). In total, 25 (30%) of the genes 
that were regulated in mouse brain were also regulated in 
either or both of the cell lines (Fig. 2). The identity and 
expression pattern of these are shown in Table 2. The 30% 
overlap between genes regulated in mouse with those regu-
lated in the cell lines gives confidence in the analysis. The 
microarray results were further verified by qPCR analysis 
(Supplementary Table 3). Out of 15 genes found signifi-
cantly regulated on microarrays, 14 were also significantly 
regulated when analysed by qPCR although directionality 
of the response was not always the same in all conditions.
Pathway analysis of transcriptomics data
Significantly regulated genes (FDR < 20%) were subjected 
to targeted biological network analysis on the  Ingenuity® 
Pathway Analysis  (IPA®) platform (Supplementary 
Table 4A-D). Categories with < 3 genes were removed and 
non-redundant categories that were significantly enriched 
(p < 0.05) in brain and at least two cell culture conditions 
are shown in Fig. 3.
Canonical pathways for ‘GADD45 Signaling’, ‘ATM Sign-
aling’, ‘Pancreatic Adenocarcinoma Signaling’, ‘ATM Signal-
ing’, ‘14-3-3-mediated Signaling’ and UVA-Induced MAPK 
Signaling’ were significantly affected in four out of the five 
conditions investigated (Fig. 3). Enrichment testing of the 
gene-lists against ‘Diseases & Functions’ annotations revealed 
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that HBCD caused differential expression of genes preferen-
tially related to (1) cell proliferation, (2) cancer, (3) apoptosis, 
(5) cytoskeleton, and (4) neuromuscular diseases (Fig. 3).
Upstream regulator analysis in  IPA® is a prediction of 
the transcriptional cascade based on the number of targets 
of “transcriptional regulators” in the dataset compared with 
those in the  IPA® database. Broadly, the implicated upstream 
regulators may be divided into (1) steroid and sex hormones, 
(2) calcium and zinc regulation-related, (3) kinase cascades, 
(4) cytokine and growth-factor response, (5) neurodegen-
erative disease, (6) and xenobiotic response. Genes in tran-
scriptional networks known to be regulated by ‘beta-estra-
diol’, ‘dihydrotestosterone’, ‘PRL’ (prolactin), ‘calcitrol’ 
(1,25-dihydroxycholecalciferol), ‘ERBB2’ (Erb-B2 Recep-
tor Tyrosine Kinase 2; aka HER2), ‘camptothecin’, ‘CSF2’ 
(Colony Stimulating Factor 2), ‘trichostatin A’, ‘lipopoly-
saccharide’, ‘STAT3’ (Signal transducer and activator of 
transcription 3), ‘STAT5a/b’, ‘TP73’ (Tumor Protein P73) 
were enriched in all five conditions, implicating these as key 
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Fig. 1  Viability of N2A and NSC19 cells exposed to HBCD: a N2A 
and b NSC19 cells were incubated for 48 h with a geometric series 
of concentration between 1.56 and 50  µM of HBCD and viabil-
ity was measured with the MTT assay. Three independent experi-
ments were performed using eight replicates in each, and the average 
between replicates and experiments are reported (n  =  3) with error 
bars showing the standard deviation. The regression curves were fit-
ted in SigmaPlot (Version 12), using the “Exponential Decay, Single, 
3 Parameter” model. The cellular viability is express in percentage of 
the DMSO control. A caspase-3 assay was used as indicator of apop-
tosis in the a N2A cell line and b in the NSC19 cell line exposed to 
HBCD. The two cell cultures were incubated for 24 h with four dif-
ferent concentrations of HBCD (1, 2, 4 or 8 µM). A caspase-3 fluo-
rescence assay was then performed and the fluorescence measured 
every 15  min in a microplate reader with 485  nm excitation and 
530 nm emission, and is here expressed in arbitrary units. Three inde-
pendent experiments were performed using eight replicates in each, 
and the average between replicates and experiments are reported 
(n = 3). Error bars denote standard deviation and an asterisk repre-
sents a p < 0.05
Table 1  Number of differentially expressed genes (FDR 20%) in 
brains of mice, N2A cell line, and NS19 cell line, following exposure 
to HBCD
Mice were exposed to a daily oral HBCD dose of 199  mg/kg for 
28 days and cell lines were exposed for 24 h. The exposure concentra-
tion indicated for brain is that measured in brain tissue
a Concentration in brain tissue (µmol/kg wet weight). Mice were 
exposed to HBCD in the diet for 28 days at a daily dose of 199 mg/
kg body weight
Analysis Concen-
tration 
(µM)
Numbers of 
regulated 
genes
Up regulation Down regu-
lation
Brain 7.9a 83 10 73
N2A 1 27 22 5
N2A 2 3265 1599 1666
NSC19 1 796 342 454
NSC19 2 356 157 199
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networks explaining the responses to HBCD (Fig. 3). The 
prediction of ‘l-glutamic acid’ and ‘kainic acid’ as upstream 
regulators is also interesting as it implicates specific effects 
on glutamatergic neurons.
Upon examining the prediction of upstream regulators 
by  IPA® the large numbers of networks known to be influ-
enced by and/or interfering with intracellular  Zn2+ and  Ca2+ 
signals was striking (Fig. 3). These also included ‘zinc’ and 
‘Ca2+’ themselves. Furthermore, glutamatergic receptor acti-
vation, as implicated through ‘l-glutamic acid’ and ‘kainic 
acid’ as upstream regulators, results in a post-synaptic rise 
in intracellular  [Ca2+], an effect that in many neurons is 
modulated my  Zn2+ (Marger et al. 2014; Sensi et al. 2011; 
Sunuwar et al. 2017). The predominance of  Zn2+ and  Ca2+ 
regulated networks prompted us to further investigate the 
effects of HBCD on neuronal  Zn2+ and  Ca2+ signalling, 
focussing on glutamatergic neurons.
HBCD‑evoked  Zn2+ signals in N2A cells
The potential of HBCD to trigger  Zn2+ signals was investi-
gated in N2A cells using the  Zn2+-specific probe, Zinpyr-1. 
For this experiment whole cell population fluorescence 
was recorded as a relative cumulative measure of intracel-
lular  [Zn2+]i and we found that exposure of cells to 1 µM 
HBCD caused on average a 1.2–1.4-fold increase in  [Zn2+]i 
(p < 0.05; Fig. 4a, b). Thus, HBCD does evoke  Zn2+ signals 
in N2A cells.
Application of 1 µM of the membrane permeable zinc 
chelator, diethyldithiocarbamate (DEDTC) completely 
abolished the  Zn2+ signal, confirming that fluorescence 
was caused by intracellular  Zn2+ release (Fig. 4a, b). Zinc 
is released from metallothioneins and other proteins in 
cells by an increase in the redox potential (Berendji et al. 
1997; Chung et al. 2006). Therefore, 1 µM N-acetyl cysteine 
(NAC) was added to the culture medium to test if the  Zn2+ 
release was caused by HBCD-induced oxidative stress. NAC 
is a substrate for biosynthesis of reduced glutathione, which 
is the most abundant antioxidant in cells (Kerksick and Wil-
loughby 2005). Addition of NAC partially alleviated HBCD-
induced  Zn2+ release compared with 1 µM HBCD alone, 
suggesting that oxidative stress was involved (Fig. 4a). Since 
nitric oxide (NO) pathway activation is a main cause of oxi-
dative stress damage in cells, proteins and lipids (Chung 
2010), we hypothesised that HBCD might activate nitric 
oxide synthase, leading to NO production and nitrosyla-
tion of zinc thiolate bonds in metallothioneins, leading to 
 Zn2+ release. We, therefore, investigated the  Zn2+ concen-
tration in cells exposed to HBCD following treatment with 
the NO pathway blocker L-NAME. Again, HBCD triggered 
intracellular release of  Zn2+, but contrary to our hypothesis 
treatment of cells with L-NAME did not reduce the HBCD 
evoked  Zn2+ signal, indicating that the effect is not related to 
NOS activation (Fig. 4b). In this experiment, the release of 
 Zn2+ following HBCD treatment alone was slightly but not 
significantly lower than that shown in Fig. 4a, however, the 
reversal of this signal by DEDTC was more substantial than 
in the experiment described in Fig. 4a and 1.4-fold below 
the Zinpyr-1 fluorescence in control cells. Such quantita-
tive differences between experiments can be caused by vari-
ability in Zinpyr-1 and/or DEDTC loading. Importantly, the 
significant increase of intracellular  Zn2+ by HBCD and the 
reversal of this signal by DEDTC were maintained in both 
set of experiments. Thus, it can be concluded that HBCD 
causes intracellular  Zn2+ release through oxidative stress, 
but this is not a result of nitric oxide synthase activation.
HBCD inhibition of metabotropic  Ca2+ signals 
in primary neuronal cultures
Many glutamatergic neurons co-release glutamate and  Zn2+ 
(Sensi et al. 2011; Sunuwar et al. 2017; Marger et al. 2014). 
To determine the effect of HBCD treatment on signalling 
capacity of cells in primary neuronal cultures, we wanted to 
determine the glutamate and extracellular  Zn2+ dependent 
 Ca2+ responses triggered via metabotropic receptors (Besser 
Fig. 2  Venn diagram of genes called significantly regulated (q < 0.2) 
in microarray analysis of mouse brain, N2A cells and NSC19 cells 
exposed to HBCD. Mice were exposed to HBCD via the diet for 
28 days at a dose of 199 mg/kg body weight per day, resulting in a 
HBCD concentration in the brain of 40 µmol/kg (wet weight). N2A 
and NSC19 cells were exposed to either 1 or 2 µM of HBCD for 24 h 
and the numerals shown are the combined numbers of unique genes 
called significant in the two conditions. The full lists of differentially 
regulated genes, fold-change data and associated p- and FDR can be 
found in Supplementary Table 2. The Venn diagram was constructed 
using Venny (http://bioinfogp.cnb.csic.es/tools/venny/index.html)
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et al. 2009; Ganay et al. 2015; Kato et al. 2012). We initially 
asked what is the concentration of HBCD that is toxic to pri-
mary neurons. Hippocampal neuronal cultures were treated 
with HBCD at 1, 2, or 4 µM of HBCD for 24 h and control 
neurons were treated with the solvent (DMSO). We then 
fluorescently monitored the  Ca2+ responses in Fura-2 loaded 
cells by single cell recording. In control cells, application 
glutamate (200 µM) triggered a rapid rise of Fura-2 fluores-
cence (about 60–70% increase above baseline fluorescence; 
Fig. 5a, b), as previously described for these metabotropic 
intracellular  Ca2+ responses (Besser et al. 2009; Ganay et al. 
2015). The perfusing extracellular solution was  Ca2+-free, 
thus allowing measurements of the initial metabotropic 
response triggered to release  Ca2+ from endoplasmic retic-
ulum stores. Following HBCD treatment, cultures were 
stained with DAPI and as shown in the inserts Fig. 5b, cell 
survival was slightly reduced, however, Fura-2 analysis is 
performed only on the surviving neurons, which are able 
to induce esterase-dependent cleavage of the AM group. 
Hence although some of the cells did not survive, we were 
able to perform the analysis even on cultures treated with 
2 µM of HBCD. Interestingly, treatment of the cultures with 
1 µM of HBCD caused an approximately 50% decrease in 
the glutamate-dependent  Ca2+ signalling in viable neurons, 
but no further reduction was observed at higher concentra-
tions (Fig. 5a, b). We then asked if the role of  Zn2+ and 
 Ca2+ highlighted by the network analysis may represent a 
change in the response of the ZnR/GPR39, a metabotropic 
pathway that senses changes in extracellular  Zn2+ to trigger 
 Ca2+ signalling (Besser et al. 2009; Ganay et al. 2015). We, 
therefore, applied  Zn2+ as was previously shown to activate 
the ZnR/GPR39 (Chorin et al. 2011; Saadi et al. 2012). 
Indeed, as shown in the inserts of Fig. 5c, an intracellular 
 Zn2+ sensitive dye, Fluozin-3, did not exhibit a change of 
signal in hippocampal neurons following administration of 
 Zn2+ (200 µM) under the same conditions used to trigger 
ZnR/GPR39 signalling (dashed top-left panel). In the control 
hippocampal cells (Fig. 5c)  Zn2+ (200 µM) triggered a rapid 
rise of Fura-2 fluorescence (about 60–70% increase above 
baseline fluorescence), similar to the response to glutamate 
Table 2  Genes differentially expressed in mouse brain and cell lines
Gene symbol Entrez gene name Log2 ratio (brain) FDR (brain)
Brain+N2A+NSC19
 Etv5 ets variant 5 − 0.340 0.122
 Yars2 Tyrosyl-tRNA synthetase 2, mitochondrial − 0.328 0.048
Brain+NSC19
 Cmc2 C-x(9)-C motif containing 2 − 0.280 0.050
Brain+N2A
 Cdkn1a Cyclin-dependent kinase inhibitor 1A (p21, Cip1) − 0.570 0.050
 Hsp5a Heat shock 70 kDa protein 5 (glucose-regulated protein, 78 kDa) − 0.434 0.066
 Fosb FBJ murine osteosarcoma viral oncogene homolog B − 0.406 0.187
 Vgf VGF nerve growth factor inducible − 0.344 0.050
 Mrpl13 Mitochondrial ribosomal protein L13 − 0.318 0.050
 Syt12 Synaptotagmin XII − 0.288 0.122
 Snx16 Sorting nexin 16 − 0.272 0.048
 Txnip Thioredoxin interacting protein − 0.264 0.156
 St8sia5 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5 − 0.258 0.010
 Xbp1 X-box binding protein 1 − 0.248 0.135
 Ppp4c Protein phosphatase 4, catalytic subunit − 0.244 0.120
 Pdia6 Protein disulfide isomerase family A, member 6 − 0.242 0.172
 Fuca1 Fucosidase, alpha-l-1, tissue − 0.238 0.037
 Ostc Oligosaccharyltransferase complex subunit (non-catalytic) − 0.238 0.135
 Pdp1 Pyruvate dehyrogenase phosphatase catalytic subunit 1 − 0.222 0.174
 Fscn1 Fascin actin-bundling protein 1 − 0.220 0.048
 Otub2 OTU deubiquitinase, ubiquitin aldehyde binding 2 − 0.218 0.105
 Abhd6 Abhydrolase domain containing 6 − 0.204 0.073
 Ddx52 DEAD (Asp-Glu-Ala-Asp) box polypeptide 52 − 0.202 0.081
 Ndufb2 NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 2, 8 kDa − 0.200 0.084
 Coq4 Coenzyme Q4 0.204 0.119
 Cacfd1 Calcium channel flower domain containing 1 0.232 0.130
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(Fig. 5a). In contrast, following emptying of intracellular 
 Ca2+ stores, using Thapsigargin (200 nM) and ATP (5 µM), 
we did not detect an increase in the signal of the  Ca2+ sensi-
tive dye Fura-2 (Fig. 5c, top-right insert). Thus, we conclude 
that the application of  Zn2+, at concentrations and times 
used here, induces metabotropic signalling in hippocampal 
neurons as we have shown previously (Ganay et al. 2015; 
Saadi et al. 2012). We then studied the effect of HBCD 
on the extracellular  Zn2+ dependent  Ca2+ signalling. The 
 Zn2+-dependent  Ca2+ response in cells treated with HBCD 
was abolished resulting in about 90% inhibition of the sig-
nal by all concentrations of HBCD tested (Fig. 5c, d). The 
lower initial rates of the response to both glutamate and 
 Zn2+ suggest that metabotropic signalling is impaired by the 
HBCD treatment. This may result from partial depletion of 
the intracellular  Ca2+ stores as well as changes in the func-
tional properties or expression of the metabotropic receptors. 
Hence, while HBCD treatment yielded a small, albeit clear, 
Fig. 3  Pathway analysis of 
genes called significantly 
regulated (q < 0.2) in microar-
ray analysis of mouse brain, 
N2A cells and NSC19 cells 
exposed to HBCD. Mice were 
exposed to HBCD via the diet 
for 28 days at a dose of 199 mg/
kg body weight per day, result-
ing in a HBCD concentration 
in the brain of 40 µmol/kg 
(wet weight). N2A and NSC19 
cells were exposed to either 
1 or 2 µM of HBCD for 24 h. 
Lists of significantly regulated 
genes from each condition were 
subjected to pathway analy-
sis, using the IPA software, 
and statistical significance of 
overrepresentation of genes in 
different “Canonical Pathways” 
and “Diseases & Biofunctions” 
are shown as a heat-map along 
with predicted “Upstream 
regulators”. Only selected 
pathways that had significant 
enrichment in mouse brain 
plus two cell culture conditions 
are shown. The full data-set 
including genes in each pathway 
is presented in Supplementary 
Tables 4A–D
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metabotropic response to glutamate, the response to  Zn2+ 
was largely absent in the treated cells.
Discussion
Omics technologies enable experiments that can implicate 
molecular networks affected by toxicants and shed light on 
key events in adverse outcome pathways (AOPs) (EFSA 
2014). Because omics profiling can be carried out without 
prior hypothesis, they can be considered unbiased and dis-
covery-driven. In the present study, we sought to character-
ise robust transcriptomic responses to HBCD by combining 
gene expression profiles resulting from in vivo and in vitro 
exposures. We compared gene expression profiles in brain 
of juvenile mouse orally exposed for 28 days to HBCD to 
those in two neuronally derived cell lines exposed to HBCD 
for 1 day, and were able to implicate a number of gene net-
works that were affected both in vivo and in vitro. These 
gene sets included networks previously identified as being 
targeted by HBCD (hypothalamus-pituitary–gonadal axis; 
 Ca2+ signalling), but interestingly also shed light on several 
new pathways that were affected. Some of the more notable 
of these were pathways involved in DNA repair and cell 
proliferation, and transcriptional networks activated by zinc 
signals, tyrosine kinase receptors, inflammation, and reactive 
oxygen species.
A few previous studies have focussed on transcript and 
protein profiling in the liver of rodents and zebrafish treated 
with HBCD, and these collectively provide very strong evi-
dence for interference with basic metabolic pathways (glu-
coneogenesis/glycolysis, amino acid/protein metabolism, 
lipid metabolism) and stress responses (Canton et al. 2008; 
Kling and Forlin 2009; Miller et al. 2016). However, cul-
tured human cell lines from lung (A549) and liver (HepG2/
C3A) showed few changes in global transcript and metabo-
lite profiles in response to HBCD concentrations up to 2 µM 
(Zhang et al. 2015). Oral exposure of female Balb/c mice 
to HBCD with the same exposure regime and conditions 
as in the present study was previously found by our team to 
result in differential expression of 90 genes and 10 proteins 
(Rasinger et al. 2014). The list of differentially expressed 
genes in our previous study was particularly enriched for 
olfactory receptors, G-coupled proteins, and protein tyrosine 
phosphatases (Rasinger et al. 2014). In the present study, 
the number of differentially regulated genes in mouse brain 
following HBCD exposure (83 genes) was very similar to 
that in our earlier experiment (90 genes). Many of the genes 
found to be regulated in our previous study were also dif-
ferentially expressed in mouse brain and neuronal cell lines 
in the present study.
IPA analysis revealed a strong inference of neuronal 
dyshomeostasis of  Ca2+ and  Zn2+ and implication of 
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Fig. 4  Intracellular  [Zn2+] in N2A cells exposed to HBCD for 24 h. N2A 
cells were exposed to HBCD with or without other treatments for 24 h 
and intracellular  Zn2+ release was detected using the  Zn2+-specific fluo-
rescent probe, Zinpyr-1. a N2A cells were incubated for 24 h with 1 µM 
HBCD with or without 2 h pre-incubation with the antioxidant, NAC, or 
the zinc chelator, DEDTC. b The N2A cell line was incubated for 24 h 
with 1 µM HBCD with or without 2 h pre-incubation with the NO syn-
thase blocker, L-NAME or with DEDTC. The experiment was carried out 
three times with 16 technical replicates in each experiment (n = 3). Data 
are expressed as fold-change of fluorescence measured in the control. The 
bars represent the averages of values from the three experiments and error 
bars show the standard deviation. An asterisk and a hash sign indicate a 
statistical differences from untreated control cells and cells treated with 
1 µM HBCD, respectively (ANOVA, p < 0.05)
1199Archives of Toxicology (2018) 92:1189–1203 
1 3
C 
A B 
D 
CTL 1µM 2µM 
0.00
0.01
0.02
0.02
0.03
0.04
Glut-dependent Ca2+ response 
** 
** 
R
at
e 
of
 C
a2
+  
re
sp
on
se
 (
R
/s
) 
CTL 
HBCD (1µM) 
0.
1R
 
50s 
Glut
Zn2+ 
CTL 
HBCD (1µM) 
0.
1R
 
50s 
0
0.01
0.02
0.03
0.04
Zn2+-dependent Ca2+ response 
** ** 
R
at
e 
of
 C
a2
+  
re
sp
on
se
 (
R
/s
) 
Zn2+ 
50s
0.
2F
FluoZin-3 Thapsi+ATP 
Zn2+ 
50s 
1R
 
Fig. 5  HBCD effects on glutamate- and zinc-dependent  Ca2+ tran-
sients. Primary hippocampal mixed neuronal cultures were exposed 
to 1 or 2 µM of HBCD for 24 h. Cells were loaded with Fura-2 AM 
and intracellular  Ca2+ responses to (a, b) glutamate (200 µM, 30  s) 
or (c, d)  Zn2+ (200 µM, 30 s) were monitored. A representative  Ca2+ 
response (a, c) and the averaged initial rates of fluorescence change 
(b, d) are shown. Note that the  Ca2+ response is monitored after a 
short lag time following the application of the ligand, likely due to 
the timing of the perfusion system. The initial rate of the response 
is dependent on the net influx of  Ca2+ into the cytoplasm and repre-
sents the activity of GPR39. Inserts to b show representative DAPI 
staining of neuronal cultures, seeded with the same number of cells, 
following control (DMSO alone) or HBCD treatment at the indicated 
concentration. Inserts to c show: left panel: neurons loaded with the 
 Zn2+ sensitive dye, Fluozin-3 AM, treated with  Zn2+ (200 µM, 30 s) 
as marked by the bar; right panel: Neurons loaded with Fura-2 AM, 
treated with Thapsigargin (200  nM) and ATP (5  µM) as marked, 
and subsequent to the depletion of  Ca2+ stores and recovery of the 
fluorescent signal to baseline,  Zn2+ (200  µM, 30  s) was applied as 
marked. The bars represent the arithmetic mean of three independent 
experiments, each consisting of at least 7 averaged replicates for each 
condition (n = 3), **p < 0.01
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glutamatergic neurons being affected. We carried on with 
mechanistic studies in cultured cells to show that HBCD 
does indeed disrupt both  Ca2+ and  Zn2+ signalling in neu-
rons. Effects of HBCD on calcium homeostasis have been 
described before in cell lines of neuronal and cardiac origin 
(Al-Mousa and Michelangeli 2014; Dingemans et al. 2009; 
Wu et al. 2016b) and are now corroborated by in vivo evi-
dence, based on transcriptional networks in mouse brain, 
and targeted experimental information on reduced  Ca2+ 
transients in response to glutamate in isolated hippocampal 
neurons. The demonstration of HBCD disruption of neu-
ronal  Zn2+ homeostasis is completely novel, although this 
mechanism of action has been proposed for triclosan effects 
on rat thymocytes (Tamura et al. 2012) and 2,3,7,8-tetra-
chlorodibenzodioxin effects on brain (Rasinger et al. 2014). 
Disruption of cellular  Zn2+ homeostasis is also recognised 
as a mechanism of action for soft Lewis acid transition ele-
ment, such as cadmium and mercury (Kawanai et al. 2009; 
Predki and Sarkar 1994).
Our understanding of and appreciation for the roles of 
zinc in biology and disease of the brain has been hugely 
increased in recent years (Marger et al. 2014; McCord and 
Aizenman 2014; Sensi et al. 2011; Tamano et al. 2016). Defi-
ciency or excess of  Zn2+ can cause alteration in behaviour, 
abnormal central nervous system development, and neu-
rological disease (Bitanihirwe and Cunningham 2009). In 
the brain,  Zn2+ modulates neuronal post-synaptic potentials 
and synaptic plasticity, and is implicated in the processes 
of learning and memory (Marger et al. 2014; Tamano et al. 
2016). The vast majority of zinc in cells including neurons 
is bound to metalloproteins, but ionic  Zn2+ is concentrated 
in synaptic vesicles of a sub-set of glutamatergic neurons 
(also known as zincergic neurons) (Sensi et al. 2011). Syn-
aptic  Zn2+ is co-released with glutamate and acts as neu-
romodulator of N-methyl-d-aspartate (NMDA) receptors 
(Anderson et al. 2015; Pan et al. 2011; Qian and Noebels 
2005; Sensi et al. 2011; Takeda 2000) or AMPA receptors 
(Kalappa et al. 2015). The GluN2A subunit of the NMDA 
receptor has a high affinity  Zn2+-binding site that mediates 
allosteric inhibition of post-synaptic currents (Sensi et al. 
2011). There is also evidence for a physiological role of 
 Zn2+ inhibition of γ-amino butyric acid-ergic (GABAergic) 
transmission via blockage of T-type  Ca2+ channels (Grauert 
et al. 2014). Finally,  Zn2+ can evoke post-synaptic currents 
via activation of GPR39, which is a metabotropic zinc recep-
tor that stimulates  Ca2+ release in cells (Besser et al. 2009) 
and regulates neuronal excitability (Chorin et al. 2011; Gilad 
et al. 2015; Saadi et al. 2012). In the present study, we show 
that HBCD depresses glutamate and zinc evoked  Ca2+ tran-
sients in hippocampal neurons that survived the HBCD treat-
ment and were able to hydrolyse the Fura-2 AM to allow the 
measurement. Inactivation of SERCA by HBCD has been 
demonstrated, and this may lead to some depletion of the 
cytosolic  Ca2+ stores. However, we show that the inhibi-
tory effect is stronger in  Zn2+ treated cells compared to the 
glutamate treatment, suggesting that there is also a direct 
effect on the metabotropic signalling pathway and not only 
on the  Ca2+ stores.
HBCD also stimulates intracellular  Zn2+ release in N2A 
cells. The ability of NAC to partially alleviate the HBCD-
evoked  Zn2+ signal confirms that low levels of HBCD can 
generate oxidative stress (Deng et al. 2009). However, this 
effect was not caused by NOS activation as L-NAME did not 
influence  Zn2+ release. In light of the physiological roles of 
synaptic  Zn2+ in neural transmission and specific functions 
in mediating synaptic plasticity for learning and memory or 
cell death, disruption in neuronal zinc homeostasis could 
be causing adverse apical effects. For example, exposure 
to 1 µM HBCD activated caspase-3 activity in N2A and 
NSC19 cells (Fig. 1c, d) and microarray analysis revealed 
that apoptotic gene networks were affected in brain of HBCD 
exposed mice as well as in both neuronal cell lines (Fig. 3). 
Moreover,  Zn2+ and  Ca2+ cooperate in mediating neuronal 
apoptosis in response to ischemia, oxidative stress, and other 
forms of injury (McCord and Aizenman 2013, 2014). This 
interaction converges on the voltage-gated, delayed rectifier 
 K+ channel Kv2.1, which when activated and residing in the 
plasma membrane allows the efflux of  K+ required for apop-
tosis (McCord and Aizenman 2013, 2014). Kv2.1 is acti-
vated through phosphorylation by p38 MAPK and tyrosine 
kinase Src. Both these kinases are activated by intracellular 
 Zn2+ signals (Hogstrand et al. 2009; McCord and Aizenman 
2013), and p38 MAPK was a predicted upstream regulator in 
HBCD exposed mouse brain, N2A cells and NSC19 cells in 
the present study. Translocation of Kv2.1 from endosomes 
to the plasma membrane where it is active is mediated by 
syntaxin SNARE proteins downstream CaMK2 activation 
(McCord and Aizenman 2013). Interestingly, we found in 
our previous study that CaMK2 expression is regulated 
in mouse brain during HBCD exposure (Rasinger et al. 
2014) and in the present study the CaMK2 inhibitory pro-
tein, CaMKN2, was a predicted upstream regulator of gene 
expression. Furthermore, the transcript for its paralogue, 
CaMKN1, was significantly regulated in both cell lines fol-
lowing exposure to 2 µM HBCD (Supplementary Table 2). 
We, therefore, hypothesise that apoptosis in brain of HBCD 
exposed mice was triggered by the disruption of  Ca2+ and 
 Zn2+ homeostasis.
Prediction of upstream regulators following HBCD 
exposure implicated gene networks in the hypothalamus-
hypophysis-gonadal axis (GnRH1, 17ß-oestradiol, dihy-
drotestosterone) as well as prolactin (PRL) with regulation 
by 17ß-oestradiol and dihydrotestosterone being statistically 
significant in mouse brain, both cell lines, and both doses 
(Fig. 3; Supplementary Table 4B). This finding is in line 
with earlier findings that HBCD has endocrine disruption 
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potential (Hamers et  al. 2006; Krivoshiev et  al. 2016; 
Maranghi et al. 2013; van der Ven et al. 2009). Developmen-
tal exposure of Wistar rats to HBCD resulted in reduced tes-
ticular size with a lower confidence limit for a 5% effect of as 
little as 11.5 mg/kg body weight per day (van der Ven et al. 
2009). Our team has previously observed an increased serum 
testosterone concentration and testosterone/17ß-oestradiol 
ratio in female Balb/c mice undergoing the same HBCD 
exposure regime as that used in the present study [199 mg/kg 
body weight per day for 28 days; (Maranghi et al. 2013)]. In 
the present study, HBCD effects on oestrogen and androgen 
gene networks were observed not only in vivo but also on 
two different neuronal cell lines, strongly suggesting direct 
effects on sex steroid target tissue. HBCD showed both anti-
androgenic and anti-oestrogenic activity in  CALUX® sex-
steroid receptor reporter gene assays and anti-oestrogenic 
activity in a MCF-7 cell proliferation assay (Hamers et al. 
2006; Krivoshiev et al. 2016). This suggests that HBCD may 
bind to and disable sex-steroid nuclear receptors and would 
be consistent with animal data from the present and previ-
ous studies (Maranghi et al. 2013; van der Ven et al. 2009).
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